MarketPeel
Insider Trading Intelligence
DL

Dexcel Pharma Technologies Ltd.

PLX
10% OWNER · PROTALIX BIOTHERAPEUTICS, INC. · CIK 0001720007
FILING MIX · LIFETIME60%/40%
BUYS
3
SELLS
2
TOTAL VALUE
$22.24M
COMPANIES
2
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
106,486,757
AVG SELL PX
$2.27
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Dexcel Pharma Technologies Ltd., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+60.00%-5.75%-1.04%-4.71%-2.33%
14d5+40.00%-11.19%-1.48%-9.72%-8.42%
30d5+60.00%-4.06%-1.41%-2.66%+0.18%
60d5+100.00%+8.84%-2.43%+11.27%+20.79%
90d5+100.00%+0.91%+1.45%-0.55%+10.00%
180d5+100.00%-4.19%+0.21%-4.40%+21.54%
1y5+100.00%+44.18%+1.62%+42.56%+56.68%
2y5+100.00%+91.61%+21.78%+69.83%+73.12%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PLX · 3,637,314 shares · as of Jun 3, 2021
01,123,7052,247,4103,371,1154,494,820SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
FLOW · 3 buys / 2 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ROIV
ROIVANT SCIENCES LTD.
PURCHASE
4,000,000$5.00$20.00M102,849,443Nov 10, 2022Nov 14, 2022View →
ROIV
ROIVANT SCIENCES LTD.
PURCHASE
8,600$3.91$33.6K98,849,443Apr 25, 2022Apr 26, 2022View →
ROIV
ROIVANT SCIENCES LTD.
PURCHASE
31,685$3.83$121.3K98,840,843Apr 22, 2022Apr 26, 2022View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
SALE
857,506$2.25$1.93M3,637,314Jun 3, 2021Jun 3, 2021View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
SALE
61,211$2.56$156.6K4,494,820Jun 2, 2021Jun 3, 2021View →
Other insiders · PLX
Loading peer insiders…
About this filer
CIK 0001720007
ROLE
10% Owner
PRIMARY
PLX
COMPANIES
2
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001720007DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback